Skip to main content
. Author manuscript; available in PMC: 2009 Jun 20.
Published in final edited form as: Virology. 2008 Apr 28;376(1):112–123. doi: 10.1016/j.virol.2008.03.022

Fig. 2.

Fig. 2

Complement-mediated neutralization of SV5 and MuV is by the alternative pathway. One hundred PFU of SV5 and MuV was incubated with either NHS, with EGTA and Mg2+-treated serum which inactivates the classical and lectin pathways, or with EDTA-treated serum which inactivates all complement pathways. Remaining infectious titers were determined by plaque assays. Results represent the average of six experiments using serum from donor number 1, with error bars representing standard deviations. Number sign, differences between EGTA-treated and EDTA-treated samples were highly significant (p < 0.001).